Evaluation and Treatment of Massive Hemoptysis - Surgical Clinics Skip to Main Content
Advertisement Surgical Clinics Log in Register Log in Subscribe Claim Skip menu theclinics.com …

Background Tranexamic acid (TA) is an antifibrinolytic drug currently used systemically to
control bleeding. To date, there have been no prospective studies of the effectiveness of …

Flexible bronchoscopy plays a critical role in both diagnostic and therapeutic management
of a variety of pulmonary disorders in the bronchoscopy suite and the intensive care unit. In …

Simple Summary This review explores hemoptysis in cancer patients. It delves into risk
factors, epidemiology and clinical consequences. The need for a mortality prediction score …

Background National data on bronchoscopy for the evaluation of acute respiratory failure
are lacking, and the limited available data suggest wide variation in use. Research Question …

Lung cancer is one of the most prevalent and lethal cancers worldwide (1). The traditional
treatments include surgery, chemotherapy, radiotherapy and interventional therapy. The …

Post-tuberculosis lung disease (PTLD) is emerging as a significant area of global interest.
As the number of patients surviving tuberculosis (TB) increases, the subsequent long-term …

Massive hemoptysis is a high-risk, low-frequency clinical scenario, and teaching the
management of this emergency should extend beyond reliance on clinical exposure …

Abstract Background The Guidelines for the Management of Cough and Sputum (2019) of
the Japanese Respiratory Society (JRS) were the first internationally published guidelines …

Background Currently, there is a lack of research on multi-drug resistant Pseudomonas
aeruginosa (MDR-PA) isolation in bronchiectasis-related hemoptysis. The aim of this study …